Seizures in Alzheimer disease: who, when, and how common?

BACKGROUND Transient symptoms in Alzheimer disease (AD) are frequent and include seizures, syncope, and episodes of inattention or confusion. The incidence of seizures in AD and predictors of which patients with AD might be more predisposed to them is based primarily on retrospective studies and is not well established. OBJECTIVE To determine the incidence and predictors of new-onset unprovoked seizures. DESIGN Prospective cohort study. SETTING Three academic centers. Patients Four hundred fifty-three patients with probable AD observed prospectively from mild disease stages since 1992. Main Outcome Measure Informant interviews every 6 months included questions about whether the patient had a seizure (convulsion, fainting, or "funny" spell) and whether diagnosis or treatment for epilepsy or seizure was made. Two epileptologists independently retrospectively reviewed all available medical records for 52 patients with positive responses to either of these questions, and using a specific checklist form, events were diagnosed as to whether they were unprovoked seizures (intrarater concordance, kappa = 0.67). Diagnosis of unprovoked seizures constituted the event in survival analyses. Potential predictors included sex, age, race/ethnicity, educational achievement, duration of illness, baseline cognition and function, depression, medical comorbidities, and time-dependent use of cholinesterase inhibitors and neuroleptic agents, apolipoprotein E genotype, and previous electroencephalographic findings. RESULTS Over the course of 3518 visit-assessments (per patient: mean, 7.8; maximum, 27), 7 patients (1.5%) developed seizures. Younger age was associated with higher risk (hazard ratio, 1.23; 95% confidence interval, 1.08-1.41; P = .003 for each additional year of age) of seizure incidence. No other predictor was significant. The overall incidence of seizures was low (418 per 100 000 person-years of observation) although significantly higher than expected for idiopathic unprovoked seizures in similar age ranges of the general population (hazard ratio, 8.06; 95% confidence interval, 3.23-16.61). CONCLUSIONS Unprovoked seizures are uncommon in AD, but they do occur more frequently than in the general population. Younger age is a risk factor for seizures in AD.

[1]  K. Nakken,et al.  The accuracy of self-reported history of seizures in Danish, Norwegian and U.S. twins , 2009, Epilepsy Research.

[2]  Yaakov Stern,et al.  Disruptive behavior as a predictor in Alzheimer disease. , 2007, Archives of neurology.

[3]  S Shinnar,et al.  Practice Parameter: Evaluating an apparent unprovoked first seizure in adults (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society , 2007, Neurology.

[4]  Anatol C. Kreitzer,et al.  Aberrant Excitatory Neuronal Activity and Compensatory Remodeling of Inhibitory Hippocampal Circuits in Mouse Models of Alzheimer's Disease , 2007, Neuron.

[5]  Yaakov Stern,et al.  Incidence and Predictors of Seizures in Patients with Alzheimer's Disease , 2006, Epilepsia.

[6]  M. Albert,et al.  Depressive Symptoms in Alzheimer's Disease: Natural Course and Temporal Relation to Function and Cognitive Status , 2005, Journal of the American Geriatrics Society.

[7]  M. Albert,et al.  Delusions and hallucinations are associated with worse outcome in Alzheimer disease. , 2005, Archives of neurology.

[8]  J. Brandt,et al.  Motor signs predict poor outcomes in Alzheimer disease , 2005, Neurology.

[9]  J. Brandt,et al.  Motor signs during the course of Alzheimer disease , 2004, Neurology.

[10]  B. Tycko,et al.  APOE-dependent PET patterns of brain activation in Alzheimer disease , 2004, Neurology.

[11]  M. Albert,et al.  Association between the APOE genotype and psychopathologic symptoms in Alzheimer’s disease , 2002, Neurology.

[12]  W. Hauser,et al.  Descriptive epidemiology of epilepsy: contributions of population-based studies from Rochester, Minnesota. , 1996, Mayo Clinic proceedings.

[13]  W. Hauser,et al.  Dementia and adult-onset unprovoked seizures , 1996, Neurology.

[14]  L. Volicer,et al.  Effect of seizures on progression of dementia of the Alzheimer type. , 1995, Dementia.

[15]  M. Mendez,et al.  Seizures in Alzheimer's Disease: Clinicopathologic Study , 1994, Journal of geriatric psychiatry and neurology.

[16]  M. Albert,et al.  Age at onset of Alzheimer's disease , 1994, Neurology.

[17]  W. Hauser,et al.  Incidence of Epilepsy and Unprovoked Seizures in Rochester, Minnesota: 1935–1984 , 1993, Epilepsia.

[18]  K. Marder,et al.  The Columbia University Scale for Psychopathology in Alzheimer's disease. , 1992, Archives of neurology.

[19]  J. Hixson Apolipoprotein E polymorphisms affect atherosclerosis in young males. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[20]  C. Stefanis,et al.  Moclobemide (Ro 11‐1163) in long‐term treatment , 1990, Acta Psychiatrica Scandinavica Supplementum.

[21]  J. Morris,et al.  Advanced Alzheimer's disease is a risk factor for late-onset seizures. , 1990, Archives of neurology.

[22]  L. Gwyther,et al.  Early‐onset Alzheimer's disease , 1987, Neurology.

[23]  Yaakov Stern,et al.  Modified Mini-Mental State Examination: Validity and Reliability , 1987 .

[24]  G. Schroth,et al.  Early diagnosis of herpes simplex encephalitis by MRI , 1987, Neurology.

[25]  W. Hauser,et al.  Seizures and myoclonus in patients with Alzheimer's disease , 1986, Neurology.

[26]  R. Mayeux,et al.  Heterogeneity in dementia of the Alzheimer type , 1985, Neurology.

[27]  J. Lawless Statistical Models and Methods for Lifetime Data , 1983 .

[28]  B. Seltzer,et al.  A comparison of clinical features in early- and late-onset primary degenerative dementia. One entity or two? , 1983, Archives of neurology.

[29]  R. Mayeux,et al.  Depression, intellectual impairment, and Parkinson disease , 1981, Neurology.

[30]  J. R. Landis,et al.  The measurement of observer agreement for categorical data. , 1977, Biometrics.

[31]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[32]  M. Roth,et al.  The Association Between Quantitative Measures of Dementia and of Senile Change in the Cerebral Grey Matter of Elderly Subjects , 1968, British Journal of Psychiatry.

[33]  H. Sjögren Clinical Analysis of Morbus Alzheimer and Morbus Pick , 1953 .

[34]  A Hofman,et al.  Clinical features and mortality in patients with early-onset Alzheimer's disease. , 1996, European neurology.

[35]  M. Albert,et al.  Multicenter Study of Predictors of Disease Course in Alzheimer Disease (the “Predictors Study”). I. Study Design, Cohort Description, and Intersite Comparisons , 1993, Alzheimer disease and associated disorders.

[36]  S. M. Sumi,et al.  Myoclonus, Seizures, and Paratonia in Alzheimer Disease , 1990, Alzheimer disease and associated disorders.

[37]  L. Gwyther,et al.  Early-onset Alzheimerʼs disease: clincal predictors of institutionalization and death , 1988 .

[38]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.

[39]  R. Sulkava Alzheimer's disease and senile dementia of Alzheimer type. A comparative study. , 1982, Acta neurologica Scandinavica.